微生物群来源的corisin在SARS-CoV-2感染期间凝血激活中的作用
本横断面研究纳入47例连续就诊的COVID-19症状患者,发现患者循环corisin、凝血酶-抗凝血酶复合物、D-二聚体、肿瘤坏死因子-α及单核细胞趋化蛋白-1水平显著升高,游离蛋白S水平降低,且凝血酶-抗凝血酶复合物、D-二聚体与corisin水平显著相关。小鼠急性肺损伤模型及体外实验显示,抗corisin中和单克隆抗体可抑制炎症反应和凝血系统激活,corisin可增加组织因子活性并降低血栓调节素的抗凝活性。
要点
- COVID-19患者循环corisin、凝血酶-抗凝血酶复合物、D-二聚体水平显著升高,游离蛋白S降低。
- 凝血酶-抗凝血酶复合物、D-二聚体与corisin水平显著相关。
- corisin可增加上皮、内皮及单核细胞的组织因子活性并降低血栓调节素抗凝活性。
核心结论
- 微生物群来源的corisin在SARS-CoV-2感染期间显著升高并与凝血系统激活相关,corisin可能直接增加上皮、内皮和单核细胞的促凝活性。
研究设计与样本
- 横断面研究纳入47例连续就诊的COVID-19症状患者,并使用小鼠急性肺损伤模型及A549肺泡上皮细胞、THP-1细胞和人脐静脉内皮细胞进行体外实验。
主要发现
- 与健康受试者相比,COVID-19患者循环corisin、凝血酶-抗凝血酶复合物、D-二聚体、肿瘤坏死因子-α和单核细胞趋化蛋白-1水平显著升高,游离蛋白S水平降低。
- 凝血酶-抗凝血酶复合物、D-二聚体和corisin水平显著相关。
- 在SARS-CoV-2刺突蛋白相关急性肺损伤小鼠模型中,抗corisin中和单克隆抗体显著抑制炎症反应和凝血系统激活,且corisin与凝血酶-抗凝血酶复合物水平显著相关。
- 体外实验中,corisin增加上皮、内皮和单核细胞的组织因子活性并降低血栓调节素的抗凝活性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coagulopathy is a major cause of morbidity and mortality in COVID-19 patients. Hypercoagulability in COVID-19 results in deep vein thrombosis, thromboembolic complications, and diffuse intravascular coagulation. Microbiome dysbiosis influences the clinical course of COVID-19. However, the role of dysbiosis in COVID-19-associated coagulopathy is not fully understood. OBJECTIVES: The present study tested the hypothesis that the microbiota-derived proapoptotic corisin is involved in the coagulation system activation during SARS-CoV-2 infection. METHODS: This cross-sectional study included 47 consecutive patients who consulted for symptoms of COVID-19. A mouse acute lung injury model was used to recapitulate the clinical findings. A549 alveolar epithelial, THP-1, and human umbilical vein endothelial cells were used to evaluate procoagulant and anticoagulant activity of corisin. RESULTS: COVID-19 patients showed significantly high circulating levels of corisin, thrombin-antithrombin complex, D-dimer, tumor necrosis factor-α, and monocyte-chemoattractant protein-1 with reduced levels of free protein S compared with healthy subjects. The levels of thrombin-antithrombin complex, D-dimer, and corisin were significantly correlated. A monoclonal anticorisin-neutralizing antibody significantly inhibited the inflammatory response and coagulation system activation in a SARS-CoV-2 spike protein-associated acute lung injury mouse model, and the levels of corisin and thrombin-antithrombin complex were significantly correlated. In an in vitro experiment, corisin increased the tissue factor activity and decreased the anticoagulant activity of thrombomodulin in epithelial, endothelial, and monocytic cells. CONCLUSION: The microbiota-derived corisin is significantly increased and correlated with activation of the coagulation system during SARS-CoV-2 infection, and corisin may directly increase the procoagulant activity in epithelial, endothelial, and monocytic cells.
引用
- Tsuruga T, Fujimoto H, Yasuma T, et al. Role of microbiota-derived corisin in coagulation activation during SARS-CoV-2 infection. J Thromb Haemost. 2024. PMID: 38453025. doi:10.1016/j.jtha.2024.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。